Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent

European Journal of Pharmacology

Volumn 231, Issue 2, 1993, Pages 313-314

  Fride, Ester ^a   Mechoulam, Raphael ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Cannabinoids; Marihuana; Tetrahydrocannabinol

Indexed keywords

ANANDAMIDE; CANNABINOID; CANNABINOID RECEPTOR; DELTA8 TETRAHYDROCANNABINOL; DRUG RECEPTOR; PSYCHOTROPIC AGENT;

ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CATALEPSY; CONTROLLED STUDY; FEMALE; HOT PLATE TEST; HYPOTHERMIA; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL;

AMIDES; ANIMAL; BEHAVIOR, ANIMAL; BODY TEMPERATURE; BRAIN CHEMISTRY; FATTY ACIDS, UNSATURATED; FEMALE; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; RECEPTORS, DRUG; STIMULATION, CHEMICAL; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TETRAHYDROCANNABINOL;

EID: 0027467421     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(93)90468-W     Document Type: Article

References (6)

1. Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents
2. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
3. Cannabinoid pharmacology
4. Behavioral, biochemical, and molecular modeling evaluatins of cannabinoid analogs
5. The ring test: a quantitative method for assessinbg the “cataleptic” effect of Cannabis in mice
6. The central pharmacology of psychotropic cannabinoids